MedTrace Logo

To Evaluate the Efficacy and Safety of the Insulin Patch Pump System in Patients With Diabetes.

NCT07403565 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 161

Last updated 2026-02-11

No results posted yet for this study

Summary

Patients will be enrolled and randomly assigned to either the test group or the control group for short-time intensive insulin therapy in inpatient setting. The test group will receive treatment with the Insulin Patch Pump System, while the control group will be treated with the Medtronic MMT-1805 insulin pump (MiniMed 700). The treatment period will last 7 days, during which blood glucose monitoring will be conducted in both groups.

Conditions

Interventions

DEVICE

Insulin Patch Pump System

patients who enrolled in this group use the Insulin Patch Pump System

DEVICE

Minimed 700

patients who enrolled in this group use Minimed 700

Sponsors & Collaborators

  • Suzhou Hechun Medical Technology Co., Ltd.

    lead INDUSTRY

Principal Investigators

  • Xiaohui Guo, Doctor · Peking University First Hospital

  • Zhifeng Cheng, Doctor · The Fourth Hospital of Harbin Medical University

  • Meng Ren, Doctor · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

  • Qi Xu, Doctor · Second Affiliated Hospital of Shantou University Medical College

  • Yu Liu, Doctor · Nanjing Medical University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-06-14
Primary Completion
2025-11-08
Completion
2025-12-03

Countries

  • China

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07403565 on ClinicalTrials.gov